One sticking point of the bill is the lack of provision that's been key for progressives—that federal officials be authorized to negotiate prices directly on at least 250 drugs. (Photo: Shutterstock)
It was negotiated behind closed doors, with progressive Democrats shut out of the process, so it's an open question how they'll react when House Speaker Nancy Pelosi, D-CA, unveils her drug pricing bill.
Politico reports that the agreement has left progressives in the dark; they fear that it will fall substantially short of their goals to cut drug prices for Americans. Pelosi's goal is to get the legislation passed by Thanksgiving, but with details scarce it's tough to predict how successful that will be.
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Marlene Satter
Marlene Y. Satter has worked in and written about the financial industry for decades.
